Status:
UNKNOWN
Dietary Modifications Effect on Continuous LCIG Infusion Outcomes in Patients With Advanced Parkinson&Apos;s Disease
Lead Sponsor:
Sheba Medical Center
Collaborating Sponsors:
Tel Aviv University
Conditions:
Parkinson Disease
Eligibility:
All Genders
40-80 years
Phase:
NA
Brief Summary
To evaluate the role of dietary modifications of 3 different diets on clinical outcomes in patients with PD treated with Duodopa®. This is in search for an optimal diet that will accompany Duodopa® tr...
Detailed Description
A prospective single-blind-crossover study in patients with PD regularly treated with Duodopa® (LICG) in which three different diets will be given. Diet A: Low fat western diet - traditional low-fat W...
Eligibility Criteria
Inclusion
- Patients treated with Duodopa at least three months and are stable on medical therapy
- Patients should be not demented, able to fill diaries and to sign an informed consent
Exclusion
- Severe dementia
- Inability to fill out diaries
- Unstable mediated condition
- Chronic renal failure
Key Trial Info
Start Date :
October 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2017
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT02274324
Start Date
October 1 2014
End Date
December 1 2017
Last Update
October 24 2014
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.